(HealthDay)—For American-Indians with type 2 diabetes, early administration of losartan does not slow progression of glomerular filtration rate (GFR) decline, according to a study published online Sept. 9 in Diabetes Care.
Sep 16, 2016
0
4
A multi-institutional team including Yale School of Medicine (YSM) has demonstrated the ability to use ultrasound to stimulate specific neurometabolic pathways in the body to prevent or reverse the onset of type 2 diabetes ...
Apr 5, 2022
0
107
A team of researchers at AstraZeneca, working with colleagues from the University of Mexico and the University of Oxford, has found that a protein tied to the MAP3K15 gene variant may represent a potential target for managing ...
People with type 1 diabetes who intensively control their blood glucose (blood sugar) early in their disease are likely to live longer than those who do not, according to research funded by the National Institutes of Health. ...
Jan 6, 2015
0
26
A recent study by investigators at the National Institute of Diabetes, Digestive and Kidney Diseases at the National Institutes of Health measured how much artificial sweetener is absorbed into the blood stream by children ...
Oct 24, 2016
2
176
March is National Kidney Month, which makes this a good time to learn about diabetic kidney disease.
Mar 17, 2022
0
7
(Medical Xpress)—The complications of uncontrolled diabetes are well recognized: nerve damage, kidney disease, blindness, and circulation problems that affect the extremities. The disease's impact on the brain, however, ...
Sep 10, 2013
0
1
Make room, cholesterol. A new disease marker is entering the medical lexicon: suPAR, or soluble urokinase-type plasminogen activator receptor. A study in the New England Journal of Medicine shows that suPAR, a circulating ...
Nov 5, 2015
0
131
The kidneys often become bulky and dysfunctional in diabetes, and now scientists have found that one path to this damage dramatically reduces the kidney's ability to clean up after itself.
Sep 22, 2020
0
114
(HealthDay)—Macrophage cyclooxygenase-2 (COX-2) deletion is associated with progression of diabetic nephropathy (DN), according to an experimental study published online Nov. 4 issue of Diabetes.
Nov 9, 2016
0
0
